Michael Solomon, MD
Family Medicine · Houston, MONPI 1093924391
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Medtronic at 51.3% of the total. Reporting peaked in 2024 at $1,715 and has fallen 95.2% since, to $82 in 2025.
Across 55 payments — averaging $71.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Bard Peripheral Vascular, Inc.$2K
- Boston Scientific$82
- Venclose Inc.$28
- BD$26
- AstraZeneca$23
- plus $47 from 3 others
What the payments were for
- Travel & lodging$2,14955%
- Food & beverage$1,75645%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 29 | $2,005 |
| Bard Peripheral Vascular, Inc. | 14 | $1,693 |
| Boston Scientific | 4 | $82 |
| Venclose Inc. | 3 | $28 |
| BD | 1 | $26 |
| AstraZeneca | 1 | $23 |
| Indivior Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ClosureFast$1,204
- Venclose Maven Catheter$428
- Abre$119
- Signia$106
How this compares
$3,905 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 27 | $4,095 |
| Diazepam | 50 | $66 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Houston
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.